These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27466490)

  • 21. Advancing biology-based therapeutic approaches for atypical teratoid rhabdoid tumors.
    Hoffman LM; Richardson EA; Ho B; Margol A; Reddy A; Lafay-Cousin L; Chi S; Slavc I; Judkins A; Hasselblatt M; Bourdeaut F; Frühwald MC; Vibhakar R; Bouffet E; Huang A
    Neuro Oncol; 2020 Jul; 22(7):944-954. PubMed ID: 32129445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors.
    Carugo A; Minelli R; Sapio L; Soeung M; Carbone F; Robinson FS; Tepper J; Chen Z; Lovisa S; Svelto M; Amin S; Srinivasan S; Del Poggetto E; Loponte S; Puca F; Dey P; Malouf GG; Su X; Li L; Lopez-Terrada D; Rakheja D; Lazar AJ; Netto GJ; Rao P; Sgambato A; Maitra A; Tripathi DN; Walker CL; Karam JA; Heffernan TP; Viale A; Roberts CWM; Msaouel P; Tannir NM; Draetta GF; Genovese G
    Cancer Cell; 2019 Feb; 35(2):204-220.e9. PubMed ID: 30753823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of a mouse model of atypical teratoid/rhabdoid tumor of the central nervous system through combined deletion of Snf5 and p53.
    Ng JM; Martinez D; Marsh ED; Zhang Z; Rappaport E; Santi M; Curran T
    Cancer Res; 2015 Nov; 75(21):4629-39. PubMed ID: 26363008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histone deacetylase inhibitor panobinostat induces antitumor activity in epithelioid sarcoma and rhabdoid tumor by growth factor receptor modulation.
    Harttrampf AC; da Costa MEM; Renoult A; Daudigeos-Dubus E; Geoerger B
    BMC Cancer; 2021 Jul; 21(1):833. PubMed ID: 34281526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predisposition to atypical teratoid/rhabdoid tumor due to an inherited INI1 mutation.
    Janson K; Nedzi LA; David O; Schorin M; Walsh JW; Bhattacharjee M; Pridjian G; Tan L; Judkins AR; Biegel JA
    Pediatr Blood Cancer; 2006 Sep; 47(3):279-84. PubMed ID: 16261613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-rhabdoid pediatric SMARCB1-deficient tumors: overlap between chordomas and malignant rhabdoid tumors?
    Renard C; Pissaloux D; Decouvelaere AV; Bourdeaut F; Ranchère D
    Cancer Genet; 2014 Sep; 207(9):384-9. PubMed ID: 25053104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
    Kohashi K; Yamada Y; Hotokebuchi Y; Yamamoto H; Taguchi T; Iwamoto Y; Oda Y
    Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathology and diagnosis of SMARCB1-deficient tumors.
    Margol AS; Judkins AR
    Cancer Genet; 2014 Sep; 207(9):358-64. PubMed ID: 25246033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel germ-line deletion of SNF5/INI1/SMARCB1 gene in neonate presenting with congenital malignant rhabdoid tumor of kidney and brain primitive neuroectodermal tumor.
    Kusafuka T; Miao J; Yoneda A; Kuroda S; Fukuzawa M
    Genes Chromosomes Cancer; 2004 Jun; 40(2):133-9. PubMed ID: 15101046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2.
    Knutson SK; Warholic NM; Wigle TJ; Klaus CR; Allain CJ; Raimondi A; Porter Scott M; Chesworth R; Moyer MP; Copeland RA; Richon VM; Pollock RM; Kuntz KW; Keilhack H
    Proc Natl Acad Sci U S A; 2013 May; 110(19):7922-7. PubMed ID: 23620515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arsenic trioxide inhibits tumor cell growth in malignant rhabdoid tumors in vitro and in vivo by targeting overexpressed Gli1.
    Kerl K; Moreno N; Holsten T; Ahlfeld J; Mertins J; Hotfilder M; Kool M; Bartelheim K; Schleicher S; Handgretinger R; Schüller U; Meisterernst M; Frühwald MC
    Int J Cancer; 2014 Aug; 135(4):989-95. PubMed ID: 24420698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Favorable outcome of patients affected by rhabdoid tumors due to rhabdoid tumor predisposition syndrome (RTPS).
    Kordes U; Bartelheim K; Modena P; Massimino M; Biassoni V; Reinhard H; Hasselblatt M; Schneppenheim R; Frühwald MC
    Pediatr Blood Cancer; 2014 May; 61(5):919-21. PubMed ID: 24123847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic Targeting of EZH2 and BET BRD4 in Pediatric Rhabdoid Tumors.
    Ishi Y; Zhang Y; Zhang A; Sasaki T; Piunti A; Suri A; Watanabe J; Abe K; He X; Katagi H; Bhalla P; Natsumeda M; Zou L; Shilatifard A; Hashizume R
    Mol Cancer Ther; 2022 May; 21(5):715-726. PubMed ID: 35247919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Achilles Heel of Malignant Rhabdoid Tumors.
    Huang J; Luo J
    Cancer Res; 2019 Jun; 79(11):2808-2809. PubMed ID: 31160308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synchronous congenital malignant rhabdoid tumor of the orbit and atypical teratoid/rhabdoid tumor--feasibility and efficacy of multimodal therapy in a long-term survivor.
    Seeringer A; Reinhard H; Hasselblatt M; Schneppenheim R; Siebert R; Bartelheim K; Leuschner I; Frühwald MC
    Cancer Genet; 2014 Sep; 207(9):429-33. PubMed ID: 25262118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug screening with a novel tumor-derived cell line identified alternative therapeutic options for patients with atypical teratoid/rhabdoid tumor.
    Nakano Y; Takadera M; Miyazaki M; Qiao Z; Nakajima K; Noguchi R; Oyama R; Kimura Y; Okuhiro Y; Yamasaki K; Kunihiro N; Fukushima H; Inoue T; Hara J; Ozawa T; Kondo T; Ichimura K
    Hum Cell; 2021 Jan; 34(1):271-278. PubMed ID: 32997328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SMARCB1 (INI1)-negative rhabdoid carcinomas of the gastrointestinal tract: clinicopathologic and molecular study of a highly aggressive variant with literature review.
    Agaimy A; Rau TT; Hartmann A; Stoehr R
    Am J Surg Pathol; 2014 Jul; 38(7):910-20. PubMed ID: 24503755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicentric atypical teratoid/rhabdoid tumors occurring in the eye and fourth ventricle of an infant: case report.
    Fujita M; Sato M; Nakamura M; Kudo K; Nagasaka T; Mizuno M; Amano E; Okamoto Y; Hotta Y; Hatano H; Nakahara N; Wakabayashi T; Yoshida J
    J Neurosurg; 2005 Apr; 102(3 Suppl):299-302. PubMed ID: 15881754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitors of histone deacetylases as potential therapeutic tools for high-risk embryonal tumors of the nervous system of childhood.
    Furchert SE; Lanvers-Kaminsky C; Juürgens H; Jung M; Loidl A; Frühwald MC
    Int J Cancer; 2007 Apr; 120(8):1787-94. PubMed ID: 17230517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid Diagnosis of an AT/RT by the Detection of a Heterozygous SMARCB1 Germ Line Deletion in an Infant.
    Kerl K; Oyen F; Giannikopoulou D; Rössig C; Rellensmann G; Sandkötter J; Brentrup A; Selzer G; Schneppenheim R; Frühwald MC
    Pediatr Blood Cancer; 2016 Aug; 63(8):1451-3. PubMed ID: 27092963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.